Methods and mechanisms for the development of MTX resistance in human lymphoid cells
Conditions are described for the development of methotrexate resistance in CCRF/CEM human lymphoid cells and an attempt is made to distinguish between those conditions that lead to methotrexate resistance through impairment of cellular transport of methotrexate and those that lead to resistance thro...
Gespeichert in:
Veröffentlicht in: | International journal of cancer 1983-01, Vol.31 (1), p.45-50 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 50 |
---|---|
container_issue | 1 |
container_start_page | 45 |
container_title | International journal of cancer |
container_volume | 31 |
creator | Alam, A. Geddes, A. J. North, A. C. T. |
description | Conditions are described for the development of methotrexate resistance in CCRF/CEM human lymphoid cells and an attempt is made to distinguish between those conditions that lead to methotrexate resistance through impairment of cellular transport of methotrexate and those that lead to resistance through enhanced production of dihydrofolate reductase. A restistant line showing a 200‐fold enhancement of dihydrofolate reductase has been obtained. The CCRF/CEM human cells are much more sensitive to methotrexate than are murine cells. |
doi_str_mv | 10.1002/ijc.2910310108 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80420779</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>13779295</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3718-59f938e5275c434c569571b71eee0f85c0cf2877f3f815a64a3ac7046aa9ff5a3</originalsourceid><addsrcrecordid>eNqFkD1PwzAQQC0EKqWwsiF5Yks5x3Fsj6jio6gVS5HYItc5K67yUeIE1H9PqlbAxnTDvXs6PUKuGUwZQHznN3YaawacAQN1QsYMtIwgZuKUjAcAIsl4ek4uQtgAMCYgGZFRqnisEjUmqyV2RZMHauqcVmgLU_tQBeqalnYF0hw_sWy2FdYdbRxdrt5pi8GHztQWqa9p0VempuWu2haNz6nFsgyX5MyZMuDVcU7I2-PDavYcLV6f5rP7RWS5ZCoS2mmuUMRS2IQnVqRaSLaWDBHBKWHBulhJ6bhTTJg0MdxYCUlqjHZOGD4htwfvtm0-egxdVvmw_8DU2PQhU5DEIKX-F2R8oGItBnB6AG3bhNCiy7atr0y7yxhk-97Z0Dv77T0c3BzN_brC_Ac_Bh72-rD_8iXu_rFl85fZH_c3SAyLXg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>13779295</pqid></control><display><type>article</type><title>Methods and mechanisms for the development of MTX resistance in human lymphoid cells</title><source>Wiley-Blackwell Journals</source><source>MEDLINE</source><creator>Alam, A. ; Geddes, A. J. ; North, A. C. T.</creator><creatorcontrib>Alam, A. ; Geddes, A. J. ; North, A. C. T.</creatorcontrib><description>Conditions are described for the development of methotrexate resistance in CCRF/CEM human lymphoid cells and an attempt is made to distinguish between those conditions that lead to methotrexate resistance through impairment of cellular transport of methotrexate and those that lead to resistance through enhanced production of dihydrofolate reductase. A restistant line showing a 200‐fold enhancement of dihydrofolate reductase has been obtained. The CCRF/CEM human cells are much more sensitive to methotrexate than are murine cells.</description><identifier>ISSN: 0020-7136</identifier><identifier>EISSN: 1097-0215</identifier><identifier>DOI: 10.1002/ijc.2910310108</identifier><identifier>PMID: 6832848</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Biological Transport ; Cell Line ; Drug Resistance ; Female ; Folic Acid Antagonists ; Humans ; In Vitro Techniques ; Lymphocytes - drug effects ; Methotrexate - pharmacology ; Tetrahydrofolate Dehydrogenase - metabolism</subject><ispartof>International journal of cancer, 1983-01, Vol.31 (1), p.45-50</ispartof><rights>Copyright © 1983 Wiley‐Liss, Inc., A Wiley Company</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3718-59f938e5275c434c569571b71eee0f85c0cf2877f3f815a64a3ac7046aa9ff5a3</citedby><cites>FETCH-LOGICAL-c3718-59f938e5275c434c569571b71eee0f85c0cf2877f3f815a64a3ac7046aa9ff5a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fijc.2910310108$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fijc.2910310108$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27915,27916,45565,45566</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6832848$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alam, A.</creatorcontrib><creatorcontrib>Geddes, A. J.</creatorcontrib><creatorcontrib>North, A. C. T.</creatorcontrib><title>Methods and mechanisms for the development of MTX resistance in human lymphoid cells</title><title>International journal of cancer</title><addtitle>Int J Cancer</addtitle><description>Conditions are described for the development of methotrexate resistance in CCRF/CEM human lymphoid cells and an attempt is made to distinguish between those conditions that lead to methotrexate resistance through impairment of cellular transport of methotrexate and those that lead to resistance through enhanced production of dihydrofolate reductase. A restistant line showing a 200‐fold enhancement of dihydrofolate reductase has been obtained. The CCRF/CEM human cells are much more sensitive to methotrexate than are murine cells.</description><subject>Biological Transport</subject><subject>Cell Line</subject><subject>Drug Resistance</subject><subject>Female</subject><subject>Folic Acid Antagonists</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Lymphocytes - drug effects</subject><subject>Methotrexate - pharmacology</subject><subject>Tetrahydrofolate Dehydrogenase - metabolism</subject><issn>0020-7136</issn><issn>1097-0215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1983</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkD1PwzAQQC0EKqWwsiF5Yks5x3Fsj6jio6gVS5HYItc5K67yUeIE1H9PqlbAxnTDvXs6PUKuGUwZQHznN3YaawacAQN1QsYMtIwgZuKUjAcAIsl4ek4uQtgAMCYgGZFRqnisEjUmqyV2RZMHauqcVmgLU_tQBeqalnYF0hw_sWy2FdYdbRxdrt5pi8GHztQWqa9p0VempuWu2haNz6nFsgyX5MyZMuDVcU7I2-PDavYcLV6f5rP7RWS5ZCoS2mmuUMRS2IQnVqRaSLaWDBHBKWHBulhJ6bhTTJg0MdxYCUlqjHZOGD4htwfvtm0-egxdVvmw_8DU2PQhU5DEIKX-F2R8oGItBnB6AG3bhNCiy7atr0y7yxhk-97Z0Dv77T0c3BzN_brC_Ac_Bh72-rD_8iXu_rFl85fZH_c3SAyLXg</recordid><startdate>19830115</startdate><enddate>19830115</enddate><creator>Alam, A.</creator><creator>Geddes, A. J.</creator><creator>North, A. C. T.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>19830115</creationdate><title>Methods and mechanisms for the development of MTX resistance in human lymphoid cells</title><author>Alam, A. ; Geddes, A. J. ; North, A. C. T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3718-59f938e5275c434c569571b71eee0f85c0cf2877f3f815a64a3ac7046aa9ff5a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1983</creationdate><topic>Biological Transport</topic><topic>Cell Line</topic><topic>Drug Resistance</topic><topic>Female</topic><topic>Folic Acid Antagonists</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Lymphocytes - drug effects</topic><topic>Methotrexate - pharmacology</topic><topic>Tetrahydrofolate Dehydrogenase - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alam, A.</creatorcontrib><creatorcontrib>Geddes, A. J.</creatorcontrib><creatorcontrib>North, A. C. T.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alam, A.</au><au>Geddes, A. J.</au><au>North, A. C. T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Methods and mechanisms for the development of MTX resistance in human lymphoid cells</atitle><jtitle>International journal of cancer</jtitle><addtitle>Int J Cancer</addtitle><date>1983-01-15</date><risdate>1983</risdate><volume>31</volume><issue>1</issue><spage>45</spage><epage>50</epage><pages>45-50</pages><issn>0020-7136</issn><eissn>1097-0215</eissn><abstract>Conditions are described for the development of methotrexate resistance in CCRF/CEM human lymphoid cells and an attempt is made to distinguish between those conditions that lead to methotrexate resistance through impairment of cellular transport of methotrexate and those that lead to resistance through enhanced production of dihydrofolate reductase. A restistant line showing a 200‐fold enhancement of dihydrofolate reductase has been obtained. The CCRF/CEM human cells are much more sensitive to methotrexate than are murine cells.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>6832848</pmid><doi>10.1002/ijc.2910310108</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0020-7136 |
ispartof | International journal of cancer, 1983-01, Vol.31 (1), p.45-50 |
issn | 0020-7136 1097-0215 |
language | eng |
recordid | cdi_proquest_miscellaneous_80420779 |
source | Wiley-Blackwell Journals; MEDLINE |
subjects | Biological Transport Cell Line Drug Resistance Female Folic Acid Antagonists Humans In Vitro Techniques Lymphocytes - drug effects Methotrexate - pharmacology Tetrahydrofolate Dehydrogenase - metabolism |
title | Methods and mechanisms for the development of MTX resistance in human lymphoid cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T18%3A50%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Methods%20and%20mechanisms%20for%20the%20development%20of%20MTX%20resistance%20in%20human%20lymphoid%20cells&rft.jtitle=International%20journal%20of%20cancer&rft.au=Alam,%20A.&rft.date=1983-01-15&rft.volume=31&rft.issue=1&rft.spage=45&rft.epage=50&rft.pages=45-50&rft.issn=0020-7136&rft.eissn=1097-0215&rft_id=info:doi/10.1002/ijc.2910310108&rft_dat=%3Cproquest_cross%3E13779295%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=13779295&rft_id=info:pmid/6832848&rfr_iscdi=true |